Anaphylaxis UHL Anaesthetic Guideline
Anaphylaxis UHL Anaesthetic Guideline
Anaphylaxis UHL Anaesthetic Guideline
1.Introduction
Anaphylaxis is a severe, life-threatening, generalized or systemic
hypersensitivity reaction. Anaphylaxis may be divided into ‘allergic
anaphylaxis’ and non-allergic anaphylaxis’. The clinical features of
allergic and non-allergic anaphylaxis may be identical.
Antibiotics are the most common trigger for anaphylaxis, followed
by muscle relaxants, chlorhexidine and Patent Blue dye.
Page 1 of 21
Guideline for the Management of Suspected Anaphylaxis During Anaesthesia
Author: Prea Ramasamy – Consultant Anaesthetist Trust Ref: C56/2016 Reviewed Dec 2018 Next Review Dec 2022
Approved by ITAPS Quaility and Saftey Board
2.Scope
HYPOTENSION
BRONCHOSPASM
Inmediate Management
Use ABCD approach
Adrenaline is the mainstay of the treatment of anaphylaxis
Remove Causative Agent
Elevate Legs
CALL FOR HELP AND INVESTIGATION BOX.
IF SYSTOLIC BLOOD PRESSURE LESS 50mmHG start CRP
as ALS guidelines
Page 2 of 21
Guideline for the Management of Suspected Anaphylaxis During Anaesthesia
Author: Prea Ramasamy – Consultant Anaesthetist Trust Ref: C56/2016 Reviewed Dec 2018 Next Review Dec 2022
Approved by ITAPS Quaility and Saftey Board
Page 3 of 21
Guideline for the Management of Suspected Anaphylaxis During Anaesthesia
Author: Prea Ramasamy – Consultant Anaesthetist Trust Ref: C56/2016 Reviewed Dec 2018 Next Review Dec 2022
Approved by ITAPS Quaility and Saftey Board
Page 4 of 21
Guideline for the Management of Suspected Anaphylaxis During Anaesthesia
Author: Prea Ramasamy – Consultant Anaesthetist Trust Ref: C56/2016 Reviewed Dec 2018 Next Review Dec 2022
Approved by ITAPS Quaility and Saftey Board
Recommendation/ Cautions
Treatment
Page 5 of 21
Guideline for the Management of Suspected Anaphylaxis During Anaesthesia
Author: Prea Ramasamy – Consultant Anaesthetist Trust Ref: C56/2016 Reviewed Dec 2018 Next Review Dec 2022
Approved by ITAPS Quaility and Saftey Board
10-There remains uncertainty about the benefits or potential
harm of administering sugammadex during resuscitation of
perioperative anaphylaxis and for management of rocuronium
induced anaphylaxis specifically. Clinical trials would provide
valuable evidence.
Departmental Organization
Page 7 of 21
Guideline for the Management of Suspected Anaphylaxis During Anaesthesia
Author: Prea Ramasamy – Consultant Anaesthetist Trust Ref: C56/2016 Reviewed Dec 2018 Next Review Dec 2022
Approved by ITAPS Quaility and Saftey Board
MAST CELL TRYPTASE
Page 9 of 21
Guideline for the Management of Suspected Anaphylaxis During Anaesthesia
Author: Prea Ramasamy – Consultant Anaesthetist Trust Ref: C56/2016 Reviewed Dec 2018 Next Review Dec 2022
Approved by ITAPS Quaility and Saftey Board
ANAESTHETIC ANAPHYLAXIS INVESTIGATIONS
Respiratory Medicine
Dr Nasreen Khan
Page 10 of 21
Guideline for the Management of Suspected Anaphylaxis During Anaesthesia
Author: Prea Ramasamy – Consultant Anaesthetist Trust Ref: C56/2016 Reviewed Dec 2018 Next Review Dec 2022
Approved by ITAPS Quaility and Saftey Board
4.Education and Training
Element to
be Lead Method Frequency Reporting
Monitored Arrangements
Datix
Anaphylaxis ITAP Incidents All ITAPS Q&S Board
events Q&S and Audits Incidents
Lead
Email to
Anaesthetic Every ITAPS Q&S Board
Referral Anaesthetic Anaphylaxis 6 months and Immunology
Compliance Anaphylaxis Mailbox and Lead
Lead Allergy
Clinic
Follow Up
6.-Supporting References
Page 11 of 21
Guideline for the Management of Suspected Anaphylaxis During Anaesthesia
Author: Prea Ramasamy – Consultant Anaesthetist Trust Ref: C56/2016 Reviewed Dec 2018 Next Review Dec 2022
Approved by ITAPS Quaility and Saftey Board
-AAGBI resources Allergies and Anaphylaxis where you can find
NAP 6 report, Quick Reference Handbook Card, link to the yellow
card, and link to British Society of Allergists and Clinic
Immunologists in the UK.
https://www.aagbi.org/safety/allergies-and-anaphylaxis
7.Key Words
8..
CONTACT AND REVIEW DETAILS
Guideline Lead (Name and Lead Committee or Executive Lead
Title) ITAPS Clinical Effectiveness Lead
Patricia Romero, Consultant
Anaesthetist P Ramasamy
Address …….………………………………………………………...............................................
Name……………………………………………………………………………..….………………....
Address…………..………….………………………………………………………………...............
……………………………………………………………………… ....………………………………...
Name……………………………………………………………………………..….………………....
Address…………..………….………………………………………………………………...............
………………………………………………………………………. ...………………………………...
Name……………………………………………………………………………..….………………....
Address…………..………….………………………………………………………………...............
………………………………………………………………………. ...………………………………...
Page 13 of 21
Guideline for the Management of Suspected Anaphylaxis During Anaesthesia
Author: Prea Ramasamy – Consultant Anaesthetist Trust Ref: C56/2016 Reviewed Dec 2018 Next Review Dec 2022
Approved by ITAPS Quaility and Saftey Board
NATIONAL AUDIT PROJECT 6
TIMELINE 1: Drugs administered in the hour before the reaction. Please include any
Perioperative
other Anaphylaxis
relevant exposures, e.g. chlorhexidine, iv colloids, Patent Blue dye
TIMELINE 2: Clinical features of the reaction and other relevant events. Please include
lowest BP, SpO2 and expired CO2.
Page 14 of 21
Guideline for the Management of Suspected Anaphylaxis During Anaesthesia
Author: Prea Ramasamy – Consultant Anaesthetist Trust Ref: C56/2016 Reviewed Dec 2018 Next Review Dec 2022
Approved by ITAPS Quaility and Saftey Board
Page 15 of 21
Guideline for the Management of Suspected Anaphylaxis During Anaesthesia
Author: Prea Ramasamy – Consultant Anaesthetist Trust Ref: C56/2016 Reviewed Dec 2018 Next Review Dec 2022
Approved by ITAPS Quaility and Saftey Board
Page 16 of 21
Guideline for the Management of Suspected Anaphylaxis During Anaesthesia
Author: Prea Ramasamy – Consultant Anaesthetist Trust Ref: C56/2016 Reviewed Dec 2018 Next Review Dec 2022
Approved by ITAPS Quaility and Saftey Board
APPENDIX 2
Date:
Patient’s name:
Patient’s address:
Hospital Number:
NHS Number:
Planned Procedure:
Consultant Surgeon:
Consultant Anaesthetist:
Dear
They will contact you with an appointment –this normally takes a few weeks.
If you have not heard in six weeks or if you have any queries please
contact me (details below).
Until you have attended the allergy clinic, you should avoid all drugs and other
potential causes you were exposed to the hour prior the allergy reaction. These
include:
o Latex
o Antibiotics (specify)
o Analgesics (specify)
It is important that you show this letter if you have any medical appointments between
now and the time of your clinic appointment.
I will write to your GP with this information.
Page 17 of 21
Guideline for the Management of Suspected Anaphylaxis During Anaesthesia
Author: Prea Ramasamy – Consultant Anaesthetist Trust Ref: C56/2016 Reviewed Dec 2018 Next Review Dec 2022
Approved by ITAPS Quaility and Saftey Board
Yours sincerely,
APPENDIX 3
Date:
Dear Dr
Your patient:
Address:
Hospital Number:
NHS Number:
Planned Procedure:
Consultant Surgeon:
Consultant Anaesthetist:
Your patient has been referred for investigation to the anaesthetic allergy clinic at
Dr Nasreen Khan,
Respiratory Consultant
Allergy Clinic
Glenfield Hospital, Leicester, LE3 9QP
01162871471
Until the patient has attended the allergy clinic, they should avoid all drugs and
potential allergens to which they are exposed during the hour prior the allergic
reaction. These include:
o Latex
o Antibiotics (specify)
o Analgesics (specify)
I have given the patient a letter providing the same information as here.
Yours sincerely,
Page 18 of 21
Guideline for the Management of Suspected Anaphylaxis During Anaesthesia
Author: Prea Ramasamy – Consultant Anaesthetist Trust Ref: C56/2016 Reviewed Dec 2018 Next Review Dec 2022
Approved by ITAPS Quaility and Saftey Board
Consultant Anaesthetist
APPENDIX 4
Page 19 of 21
Guideline for the Management of Suspected Anaphylaxis During Anaesthesia
Author: Prea Ramasamy – Consultant Anaesthetist Trust Ref: C56/2016 Reviewed Dec 2018 Next Review Dec 2022
Approved by ITAPS Quaility and Saftey Board
Pre-warn the theatre team beforehand, and be prepared to
diagnose and treat anaphylaxis promptly.
Page 20 of 21
Guideline for the Management of Suspected Anaphylaxis During Anaesthesia
Author: Prea Ramasamy – Consultant Anaesthetist Trust Ref: C56/2016 Reviewed Dec 2018 Next Review Dec 2022
Approved by ITAPS Quaility and Saftey Board
Page 21 of 21
Guideline for the Management of Suspected Anaphylaxis During Anaesthesia
Author: Prea Ramasamy – Consultant Anaesthetist Trust Ref: C56/2016 Reviewed Dec 2018 Next Review Dec 2022
Approved by ITAPS Quaility and Saftey Board